# Interactions of the EGFR juxtamembrane domain with PIP2-containing lipid bilayers: Insights from multiscale molecular dynamics simulations

**Authors:** Khairul Bariyyah Abd Halim, Heidi Koldsø, Mark S.P. Sansom

PMC · DOI: 10.1016/j.bbagen.2014.09.006 · Biochimica et Biophysica Acta · 2015-05-01

## TL;DR

This study uses simulations to show how the EGFR protein interacts with a specific lipid, PIP2, to help activate cell signaling.

## Contribution

The study reveals how PIP2 stabilizes the EGFR juxtamembrane domain, promoting its activated state through multiscale simulations.

## Key findings

- PIP2 clusters around the JM domain by interacting with basic residues R645–R647.
- Mutation or PIP2 depletion disrupts JM dimer stability and membrane interactions.
- PIP2 binding helps orient the JM domain away from the membrane, promoting activation.

## Abstract

The epidermal growth factor receptor (EGFR) is the best characterised member of the receptor tyrosine kinases, which play an important role in signalling across mammalian cell membranes. The EGFR juxtamembrane (JM) domain is involved in the mechanism of activation of the receptor, interacting with the anionic lipid phosphatidylinositol 4,5-bisphosphate (PIP2) in the intracellular leaflet of the cell membrane.

Multiscale MD simulations were used to characterize PIP2–JM interactions. Simulations of the transmembrane helix plus JM region (TM–JM) dimer (PDB:2M20) in both PIP2-containing and PIP2-depleted lipid bilayer membranes revealed the interactions of the JM with PIP2 and other lipids.

PIP2 forms strong interactions with the basic residues in the R645–R647 motif of the JM domain resulting in clustering of PIP2 around the protein. This association of PIP2 and the JM domain aids stabilization of JM-A dimer away from the membrane. Mutation (R645N/R646N/R647N) or PIP2-depletion results in deformation of the JM-A dimer and changes in JM–membrane interactions.

These simulations support the proposal that the positively charged residues at the start of the JM-A domain stabilize the JM-A helices in an orientation away from the membrane surface through binding to PIP2, thus promoting a conformation corresponding to an asymmetric (i.e. activated) kinase.

This study indicates that MD simulations may be used to characterise JM/lipid interactions, thus helping to define their role in the mechanisms of receptor tyrosine kinases. This article is part of a Special Issue entitled Recent developments of molecular dynamics.

•EGFR transmembrane–juxtamembrane dimer was simulated in PIP2-containing bilayers.•PIP2 forms favourable interactions with basic residues of the JM region.•Mutation or PIP2 depletion changes juxtamembrane interactions with the bilayer.•Simulations support interactions with anionic lipids in activation of the EGFR.

EGFR transmembrane–juxtamembrane dimer was simulated in PIP2-containing bilayers.

PIP2 forms favourable interactions with basic residues of the JM region.

Mutation or PIP2 depletion changes juxtamembrane interactions with the bilayer.

Simulations support interactions with anionic lipids in activation of the EGFR.

## Linked entities

- **Proteins:** EGFR (epidermal growth factor receptor)
- **Chemicals:** PIP2 (PubChem CID 5311358)

## Full-text entities

- **Genes:** EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}, ERBB3 (erb-b2 receptor tyrosine kinase 3) [NCBI Gene 2065] {aka ErbB-3, FERLK, HER3, LCCS2, MDA-BF-1, VSCN1}, CALM1 (calmodulin 1) [NCBI Gene 801] {aka CALML2, CAM2, CAM3, CAMB, CAMC, CAMI}, ERBB4 (erb-b2 receptor tyrosine kinase 4) [NCBI Gene 2066] {aka ALS19, HER4, p180erbB4}, RET (ret proto-oncogene) [NCBI Gene 5979] {aka CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1}, MMUT (methylmalonyl-CoA mutase) [NCBI Gene 4594] {aka MCM, MUT}, Erbb2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 24337] {aka HER2/neu, neu}, KIR2DL4 (killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4) [NCBI Gene 3805] {aka CD158D, G9P, KIR-103AS, KIR-2DL4, KIR103, KIR103AS}
- **Diseases:** cancer (MESH:D009369)
- **Chemicals:** POPS lipid (MESH:C050294), DPPC (MESH:D015060), carbon (MESH:D002244), phosphate (MESH:D010710), Lipid (MESH:D008055), PIP2 (MESH:D019269), lysine (MESH:D008239), phospholipids (MESH:D010743), PIP2 lipids (-), Arginine (MESH:D001120), cardiolipin (MESH:D002308), water (MESH:D014867), POPC (MESH:C065191)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** R647, R645N, Arg/Lys, R645N, R646, R647, R646N, R646N, R647N, R647N, R645

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4547087/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4547087/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC4547087/full.md

---
Source: https://tomesphere.com/paper/PMC4547087